Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Sarilumab 150mg/1.14ml inj pre-filled disposable devices
1001030ADAAACAC
|
Sarilumab | Sarilumab | Musculoskeletal and Joint Diseases | 1 |
|
Sarilumab 150mg/1.14ml inj pre-filled syringes
1001030ADAAAAAA
|
Sarilumab | Sarilumab | Musculoskeletal and Joint Diseases | No data available |
|
Sarilumab 200mg/1.14ml inj pre-filled disposable devices
1001030ADAAADAD
|
Sarilumab | Sarilumab | Musculoskeletal and Joint Diseases | No data available |
|
Sarilumab 200mg/1.14ml inj pre-filled syringes
1001030ADAAABAB
|
Sarilumab | Sarilumab | Musculoskeletal and Joint Diseases | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.